Metformin may shield aging muscles from inactivity

NCT ID NCT03107884

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial tests whether metformin, a widely used diabetes drug, can prevent muscle loss and insulin resistance in healthy older adults during five days of bed rest. Researchers will measure changes in muscle size and insulin sensitivity. The study involves 64 participants aged 60 and older at the University of Utah.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Metformin (an oral diabetes drug)

What this could lead to

If it works, this could point toward a way to protect muscle health in older adults during periods of inactivity, like bed rest.

What could go wrong

This is a very small, early-phase study (64 people) testing a short-term effect. Results may not apply to real-world aging or long-term use, and metformin can cause stomach upset.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Insulin Resistance muscular atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Utah

    Salt Lake City, Utah, 84108, United States